Microdosing semaglutide, typically at doses of 0.1 to 0.5 mg per week, has gained attention for researchers who want milder appetite effects, metabolic benefits without dramatic weight loss, or a more conservative approach
That doesnt change much when it comes to the net effects
Combining GLP-1 agonists (such as liraglutide, semaglutide and tirzepatide) with metformin can offer several benefits for weight loss, especially in individuals with type 2 diabetes or obesity: Synergistic Effects : GLP-1 agonists and metformin work through different mechanisms to lower blood sugar levels and promote weight loss
When attacks to the paternal genome do occur, they are commonly oxidatively induced as evidenced by the formation of the 8-hydroxy-2-deoxyguanosine (8OHdG) DNA base adduct (139141)
Appetite suppression can make it very easy to under eat
Do not use other GLP-1 RAs